UBS Faces Pivotal Regulatory and Governance Decisions This Spring

UBS navigates a board reshuffle and crucial Swiss capital regulations in April, with potential $22B in new requirements shaping its future strategy.

The coming weeks represent a critical juncture for UBS Group AG, with significant developments slated for April that will shape the Swiss banking giant’s future. The bank confronts a major regulatory review from Swiss authorities while simultaneously undergoing a substantial refresh of its board leadership.

Boardroom Reshuffle Coincides with Shareholder Meeting

A noticeable transformation at the top of UBS will be formalized at the Annual General Meeting in Basel on April 15. The bank is set to welcome two prominent new figures to its Board of Directors: Agustín Carstens, the current General Manager of the Bank for International Settlements, and Luca Maestri, the long-serving Chief Financial Officer of Apple Inc. Chairman Colm Kelleher has emphasized the complementary expertise the newcomers bring, highlighting Carstens's deep regulatory insight and Maestri's extensive financial management experience.

Their appointments coincide with the departure of three existing board members: William C. Dudley, Jeanette Wong, and Lukas Gähwiler, the latter concluding a 45-year career in banking. Shareholders will also vote on a proposed cash dividend of USD 1.10 per share for the 2025 financial year.

Swiss Government to Unveil Crucial Capital Rules

Potentially more consequential is the anticipated announcement from the Swiss Federal Council on either April 22 or 29. The government is scheduled to publish its ordinance on intangible capital, a direct regulatory response to the collapse of Credit Suisse.

Analysis from Bank of America suggests one element could provide some relief. If deferred tax assets are recognized up to a limit of ten percent of CET1 capital—consistent with Basel III standards—the related capital charge could decrease from USD 10.8 billion to approximately USD 6.2 billion.

However, a parallel proposal presents a significant challenge. Authorities are expected to maintain their stance that UBS must fully back its foreign subsidiaries with high-quality CET1 capital. The bank has previously labeled this requirement as unacceptable. Under a combined scenario incorporating both proposals, UBS internally estimates it could face additional capital requirements of around USD 22 billion compared to its position at the end of 2024. Such a figure would substantially constrain its capital planning flexibility.

Parliamentary Debate Offers Potential for Amendment

The regulatory landscape is not yet finalized. The Swiss parliament is scheduled to debate the legislation concerning foreign subsidiaries on May 4. Market experts anticipate that lawmakers may amend the draft to allow a portion of the requirements to be met with more flexible AT1 capital instruments, rather than the more expensive CET1 equity.

The government's stringent position is rooted in the systemic importance of UBS, whose balance sheet is roughly twice the size of Switzerland's entire annual economic output—a politically potent argument that is difficult to counter.

Strong Performance Amidst Uncertainty

UBS enters this period of decision-making from a position of operational strength. The bank reported a net profit of USD 7.8 billion for 2025, a 53 percent increase over the prior year. Assets under management surpassed USD 7 trillion, and cumulative cost savings from the integration of Credit Suisse reached USD 10.7 billion. Management has set a target exit rate for return on CET1 capital (RoCET1) of approximately 15 percent for 2026.

The bank will report its first-quarter 2026 results on April 29, immediately following the expected regulatory announcement. The final severity of the new capital constraints will be a primary factor in determining whether UBS can realistically achieve its ambitious profitability targets.